|
| |
| | 69700 | | 13.03.2025 | | AbbVie AG | | | | | | 12.03.2030 | | | | | | | | | | 07.16.10. | | IP |
| Seq.-No. | Product | Description | Galenic form | ATC-classification | |
---|
01 | ELAHERE 100 mg/20 ml | Konzentrat zur Herstellung einer Infusionslösung | Concentrate for infusion (Mirvetuximabum Soravtansinum 100mg / 20ml) | | |
|
|
|